Regular Article
Potent Inhibition of Dendritic Cell Differentiation and Maturation by Vitamin D Analogs

https://doi.org/10.1006/bbrc.2000.2490Get rights and content

Abstract

We show that the immunosuppressive effects of 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) are due, in part, to inhibition of the T cell stimulatory functions of dendritic cells (DCs). Addition of 10−12 and 10−8 M 1α,25(OH)2D3 to murine DC cultures resulted in a concentration-dependent reduction in levels of class II MHC and the co-stimulatory ligands B7-1, B7-2, and CD40 without affecting the number of DCs generated. Higher concentrations of 1α,25(OH)2D3 reduced DC yield. The capacity of DCs to induce proliferation of purified allogeneic T cells was reduced by 1α,25(OH)2D3. The vitamin D3 analog, 1α,25(OH)2-16-ene-23-yne-26,27-hexafluoro-19-nor-D3, exerted identical effects at 100-fold lower concentrations. Inhibition of DC maturation and stimulatory function was absent in cultures from mice genetically lacking vitamin D receptors (VDR). Vitamin D analogs effectively reduce DC function via VDR-dependent pathways.

References (42)

  • J.M. Lemire

    Immunomodulatory role of 1,25-dihydroxyvitamin D3

    J. Cell. Biochem.

    (1992)
  • J.M. Lemire et al.

    suppresses human T helper/inducer lymphocyte activity in vitro

    J. Immunol.

    (1985)
  • J.M. Lemire et al.

    1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis

    J. Clin. Invest.

    (1991)
  • M.T. Cantorna et al.

    1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

    Proc. Natl. Acad. Sci. USA

    (1996)
  • C. Fournier et al.

    In vivo

    (1990)
  • C. Mathieu et al.

    1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice

    Diabetes

    (1992)
  • D.D. Branisteanu et al.

    Partial prevention of active Heymann nephritis by 1α,25-dihydroxyvitamin D3

    Clin. Exp. Immunol.

    (1993)
  • D.A. Hullett et al.

    Prolongation of allograft survival by 1,25-dihydroxyvitamin D3

    Transplantation

    (1998)
  • A. Verstuyf et al.

    Recent developments in the use of vitamin D analogues

    Curr. Opin. Nephrol. Hypertens.

    (1998)
  • D. D'Ambrosio et al.

    Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3

    J. Clin. Invest.

    (1998)

    • Cited by (0)

    1

    To whom correspondence should be addressed at Mayo Clinic and Foundation, 200 First St. SW, Eisenberg Building S24, Rochester, MN 55905. Fax: (507) 266 7891. E-mail: [email protected].

    View full text
    Copyright © 2000 Academic Press. All rights reserved.